The rat Subcutaneous Air Sac model: A quantitative assay of antiangiogenesis in induced vessels

Pharmacology and Toxicology

Volumn 84, Issue 1, 1999, Pages 34-40

  Lichtenberg, Jens ^a   Vig Hjarnaa, Pernille Julia ^a   Kristjansen, Paul E G ^b   Hansen, Dann ^a   Binderup, Lise ^a  

^a LEO PHARMA A S   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

FUMAGILLOL CHLOROACETYLCARBAMATE;

AIR SAC; ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; CORNEA NEOVASCULARIZATION; FEMALE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; VASCULAR ENDOTHELIUM;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0032953469     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1999.tb02108.x     Document Type: Article

References (21)

1. Antoine, N., R. Greimers, C. De Roanne, M. Kusaka, E. Heinen, L. J. Simar & V. Castronovo: AGM-1470, a potent angiogenesis inhibitor, prevents the entry of normal but not transformed endothelial cells into the G1 phase of the cell cycle. Cancer Res. 1994, 54, 2073-2076.
2. Denekamp, J.: Vascular attack as a therapeutic strategy for cancer. Cancer Metast. Rev. 1990, 3, 267-282.
3. Edwards, J. C., A. D. Sedwick & D. A. Willoughby: The formation of a structure with the features of synovial lining by subcutaneous air: an in vivo tissue culture system. J. Pathology 1981, 134, 147- 156.
4. Fan, T.-P. D. & P. J. Polverini: In vivo models of angiogenesis. In: Tumor angiogenesis. Oxford University Press, Oxford, 1997, 5- 18.
5. Ferrara, N.: Vascular endothelial growth factor. Trends Cardiovasc. Med. 1993, 3, 244-250.
6. Folkman, J.: Tumor angiogenesis: The molecular basis of cancer. W. B. Saunders Publishing Co., 1995a.
7. Folkman, J.: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med. 1995b, 1, 27-31.
8. Folkman, J.: Addressing tumor blood vessels. Nature Biotech. 1997, 15, 510.
9. Gimbrone, M. A., R. S. Cotran, S. B. Leapman & J. Folkman: Tumour growth and neovascularisation: An experimental model using the rabbit cornea. J. Nat. Cancer Inst. 1974, 52, 413-427.
10. Grant, D. S., H. K. Keinman, I. D. Goldberg, M. Bhargava, B. J. Nickoloff, P. Polverini & E. M. Rosen: Scatter factor induces blood vessels formation in vivo. Proc. Natl Acad. Sci. 1993, 90, 1937-1941.
11. Hobson, B.: Endothelial proliferation in tumours and normal tissues: continuous labelling studies. Brit. J. Cancer 1994, 49, 405-413.
12. Jain, R. K., K. Schlenger, M. Höckel & F. Yuan: Quantitative angiogenesis assays: Progress and problems. Nature Med. 1997, 3, 1203-1208.
13. Klagsburn, M., J. Sasse, R. Sullivan & J. A. Smith: Human tumor cells synthesize an endothelial cell growth factor that is structurally related to basic fibroblast growth factor. Proc. Natl. Acad. Sci. 1986, 83, 2448-2452.
14. Kusaka, M., K. Sudo, T. Fujita, S. Marui, F. Itoh, D. Ingber & J. Folkman: Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent. Biochem. Biophys. Res. Commun. 1991, 174, 1070-1076.
15. Lichtenberg, J., C.A. Hansen, T. Skak-Nielsen, C. Bay, J. T. Mortensen & L. Binderup: The rat subcutaneous air sac model: A new and simple method for in vivo screening of antiangiogenesis. Pharmacology & Toxicology, 1997, 81, 280-284.
16. Liotta, L. A., P. S. Steeg & G. S. Stetler-Stevenson: Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991, 64, 327-336.
17. Muthukkaruppan, P. J. & R. Auerbach: Angiogenesis in the mouse cornea. Science 1979, 205, 1416-1418.
18. Odedra, R. & J. B. Weiss: Low molecular weight angiogenesis factors. Pharmacol Therap. 1991, 49, 111-124.
19. Shaker, A. M.: Angiogenesis promoters and inhibitors: potential therapeutic implications. In: International business communications: Therapeutic implications of angiogenesis inhibitors and stimulators. Elsevier Science Ltd. 1996, 1357-4310.
20. Voest, E. E.: Inhibitors of angiogenesis in a clinical perspective. Anti-Cancer Drugs, 1996, 7, 723-727.
21. Weiss, J. B. & B. McLaughlin: Recent developments in the treatment of angiogenesis. Exp. Opin. Ther. Patents 1996, 6, 619-625.